Adenovirus Based Coronavirus Vaccine Being Tested

Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]
HIV Vaccine Fails Clinical Trial in South Africa

Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
Stress Prevention Vaccine On the Horizon

Story Highlights Researchers at the University of Colorado Boulder say that a vaccine to prevent stress is on the horizon. According to the study, a bacterium found in soil called Mycobacterium vaccae injected into rodents showed that the injections reduced stress in the rodents. The medical literature shows that spending time in nature and handling soil significantly […]
New Foot and Mouth Disease Animal Vaccine on Fast Track

Story Highlights Global pet and animal vaccine manufacturer, Zoetis, has signed an agreement with Texas A & M to develop a new animal vaccine for foot and mouth disease (FMD). Recently agriculture groups have insisted that USDA develop FMD vaccine bank to prepare for a future FMD outbreak among livestock in the U.S., even though […]
New Herpes Vaccine Nearing Human Clinical Trials

Researchers at the University of Pennsylvania recently reported that they are close to developing a herpes simplex virus 2 (HSV-2) vaccine for humans. HSV-2 primarily causes genital herpes and is contracted through forms of sexual contact with a person who has HSV-2. An estimated 14 percent of Americans between the ages of 15 and 49 […]